D
Anebulo Pharmaceuticals, Inc. ANEB
$2.30 -$0.01-0.43% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -2.14M -1.68M -2.46M -2.20M -1.35M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 17.40K 245.20K 59.70K 59.70K 59.70K
Total Other Non-Cash Items 340.30K 255.30K 564.30K 286.90K 177.20K
Change in Net Operating Assets 135.00K -426.20K 433.30K 164.10K -939.90K
Cash from Operations -1.65M -1.60M -1.41M -1.69M -2.05M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 0.00 0.00 15.00M -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 -116.70K -- -- 0.00
Cash from Financing 0.00 -116.70K 15.00M -- 0.00
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -1.65M -1.72M 13.59M -1.69M -2.05M